Rhumbline Advisers Bionomics Limited Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Bionomics Limited stock. As of the latest transaction made, Rhumbline Advisers holds 2,195 shares of BNOX stock, worth $1,163. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,195
Previous 1,305
68.2%
Holding current value
$1,163
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BNOX
# of Institutions
12Shares Held
1.64MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY1.23MShares$650,1820.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct316KShares$167,4800.0% of portfolio
-
Ubs Group Ag34.9KShares$18,4950.0% of portfolio
-
Two Sigma Securities, LLC New York, NY26KShares$13,8000.0% of portfolio
-
Two Sigma Investments, LP New York, NY16.4KShares$8,6760.0% of portfolio
About BIONOMICS LIMITED
- Ticker BNOX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,518,620
- Market Cap $3.98M
- Description
- Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has ...